CTOs on the Move


 
XIFIN, Inc. is an innovative software and services company dedicated to optimizing the economics of healthcare. The company`s cloud-based technology and business intelligence platform links healthcare stakeholders in the delivery and reimbursement of care, optimizing both business and patient outcomes and providing informed, streamlined diagnostic and business decision-making.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.xifin.com
  • 12225 El Camino Real
    San Diego, CA USA 92130
  • Phone: 858.793.5700

Executives

Name Title Contact Details
John Kelly
Chief Information Officer Profile

Similar Companies

Q2 Solutions

Q² Solutions, a Quintiles Quest joint venture Launched in 2015, Q² Solutions (pronounced Q-squared) is a leading global clinical trials laboratory services organization. We help biopharmaceutical, medical device and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights. Q² Solutions is a quality driven, responsive partner with strong global experience and deep scientific and medical expertise. The Q² Solutions joint venture was formed by Quintiles and Quest Diagnostics, combining the best of each parent organizations clinical trials laboratory services capabilities.

Parma Care Ctr

Parma Care Ctr is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Polaris Pharmacy Services

Polaris Pharmacy Services is a leading provider of long term care pharmacy solutions in the United States. They offer enhanced clinical services, a client web portal, a web-based discharge program, HIPAA compliant communication, ePrescribing, and educa...

Clarvista Medical

ClarVista Medical` based in Aliso Viejo` California is a leading developer of innovative products to treat challenging ophthalmic conditions. In 2012 and in conjunction with series A financing` ClarVista was spun out from Prospex Medical` a medical device incubator` to pursue the development of the HARMONI™ IOL. Between 2012 and 2014` the company developed the first generation HARMONI™ system` conducted thorough first-in-human clinical study and developed a broad portfolio of intellectual property. In 2015 the company closed on a series B financing of $14M which will be used to develop the second generation HAROMONI™ system` conduct a larger feasibility clinical trial and obtain key regulatory approvals including CE mark and US IDE.

Empi

Empi, Inc is a medical device company focused on products used for pain management, orthopedic rehabilitation and physical therapy. The Company develops, manufactures, markets and distributes a diverse range of non-invasive medical devices and related